triamcinolone acetonide has been researched along with interleukin-8 in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (16.67) | 18.2507 |
| 2000's | 3 (50.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 1 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Frees, KL; Nonnenmann, MW; Quinn, TJ; Schwartz, DA; Trapp, JF; Watt, JL | 1 |
| Cagnoni, F; Canonica, GW; Giron-Michel, J; Mangraviti, S; Oddera, S; Popova, O | 1 |
| Adcock, IM; Ito, K; Punchard, N; Tsaprouni, LG | 2 |
| Afifi, MM; Mahmoud, MM | 1 |
| He, Y; Li, Y; Shao, F; Tan, Z; Zheng, S | 1 |
2 trial(s) available for triamcinolone acetonide and interleukin-8
| Article | Year |
|---|---|
The effect of of glucocorticoids on grain dust-induced airway disease.
Topics: Administration, Inhalation; Adult; Airway Obstruction; Anti-Inflammatory Agents; Bronchoalveolar Lavage Fluid; Cell Count; Cross-Over Studies; Dust; Eosinophils; Female; Follow-Up Studies; Forced Expiratory Volume; Glucocorticoids; Humans; Hydrocortisone; Infusions, Intravenous; Interleukin-8; Leukocyte Count; Macrophages, Alveolar; Male; Placebos; Pneumonia; Premedication; Single-Blind Method; Spirometry; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha; Vital Capacity; Zea mays | 1998 |
Alteration of Streptococcus salivarius in Buccal Mucosa of Oral Lichen Planus and Controlled Clinical Trial in OLP Treatment.
Topics: Administration, Topical; Adult; Aged; Anti-Inflammatory Agents; Cell Line; Female; Gene Expression; Humans; Interleukin-1beta; Interleukin-6; Interleukin-8; Lichen Planus, Oral; Male; Middle Aged; Mouth Mucosa; NF-kappa B; Streptococcus salivarius; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha | 2020 |
4 other study(ies) available for triamcinolone acetonide and interleukin-8
| Article | Year |
|---|---|
Effects of triamcinolone acetonide on adult human lung fibroblasts: decrease in proliferation, surface molecule expression and mediator release.
Topics: Cell Division; Collagen; Female; Fibroblasts; Fibronectins; Glucocorticoids; Humans; Intercellular Adhesion Molecule-1; Interferon-gamma; Interleukin-6; Interleukin-8; Lung; Male; Middle Aged; Triamcinolone Acetonide; Vascular Cell Adhesion Molecule-1 | 2002 |
Triamcinolone acetonide and dexamethasome suppress TNF-alpha-induced histone H4 acetylation on lysine residues 8 and 12 in mononuclear cells.
Topics: Acetylation; Anti-Inflammatory Agents; Dexamethasone; Histone Deacetylase Inhibitors; Histone Deacetylases; Histones; Humans; Interleukin-8; Lysine; Monocytes; Triamcinolone Acetonide; Tumor Necrosis Factor-alpha; U937 Cells | 2002 |
Suppression of lipopolysaccharide- and tumour necrosis factor-alpha-induced interleukin (IL)-8 expression by glucocorticoids involves changes in IL-8 promoter acetylation.
Topics: Acetylation; Dexamethasone; Gene Expression Regulation; Glucocorticoids; Histones; Humans; Hydroxamic Acids; Interleukin-8; Lipopolysaccharides; Lymphocytes; Macrophages; Promoter Regions, Genetic; Triamcinolone Acetonide; Tumor Cells, Cultured; Tumor Necrosis Factor-alpha | 2007 |
Anti-angiogenic therapy (bevacizumab) in the management of oral lichen planus.
Topics: Bevacizumab; Humans; Interleukin-8; Lichen Planus, Oral; Triamcinolone Acetonide; Vascular Endothelial Growth Factor A | 2016 |